Pediatric Facial Trauma

Tom W Andrew1, Roshan Morbia2, H Peter Lorenz3

  • 1Hagey Laboratory for Pediatric Regenerative Medicine, Division of Plastic Surgery, Department of Surgery, School of Medicine, Stanford University, 257 Campus Drive, Stanford, CA 94305, USA.

Insights

Pediatric facial fractures require specialized management due to unique craniofacial development. Treatment approaches vary with age, balancing conservative care with surgical options to avoid growth impairment.

Area of Science:

  • Craniofacial surgery
  • Pediatric trauma
  • Orthopedic surgery

Background:

  • Pediatric craniofacial skeleton differs significantly from adult anatomy.
  • Pediatric facial trauma is common, but fractures are less frequent than in adults.
  • Unique biomechanical properties influence fracture patterns in children.

Purpose of the Study:

  • To review the distinct aspects of pediatric facial fracture management.
  • To highlight differences between pediatric and adult facial trauma treatment.
  • To inform clinical decision-making for managing facial fractures in children.

Main Methods:

  • Literature review of pediatric facial fracture management.
  • Analysis of anatomical and biomechanical differences in pediatric skulls.
  • Discussion of age-dependent treatment strategies.

Main Results:

  • Pediatric facial fractures are less common than adult fractures despite higher trauma incidence.
  • Conservative management is often preferred in younger children to prevent growth disturbances.
  • Surgical interventions become more conventional as the pediatric facial skeleton matures.

Conclusions:

  • Pediatric facial fracture management demands a tailored approach considering skeletal immaturity.
  • Understanding unique pediatric craniofacial anatomy is crucial for effective treatment.
  • Treatment strategies must adapt to the patient's skeletal maturation stage.

Related Concept Videos

Facial Feedback Hypothesis01:24

Facial Feedback Hypothesis

Charles Darwin proposed that facial expressions are an evolutionary adaptation for communication. He argued that these expressions are not influenced by culture but are universal across species. For example, a snarling expression with exposed teeth signals a threat in many animals, including humans. Darwin also suggested that displaying an emotion can intensify the feeling. Smiling, for example, could enhance one's sense of happiness. This idea laid the foundation for understanding the role...
651
Muscles for Facial Expressions01:14

Muscles for Facial Expressions

The craniofacial muscles are a collection of approximately 20 thin skeletal muscles situated beneath the skin of the face and scalp. These muscles, primarily responsible for the vast array of human facial expressions, originate from the bones or fibrous structures of the skull and extend outwards to connect with the skin. While most skeletal muscles in the body are enveloped in thick fascia, facial muscles generally have a more delicate fascial covering, with the buccinator muscle being a...
4.8K
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
225
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
285
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
212
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
271